[Federal Register Volume 69, Number 37 (Wednesday, February 25, 2004)]
[Notices]
[Pages 8708-8709]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-4061]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Issuer Delisting; Notice of Application of Columbia Laboratories, 
Inc., To Withdraw its Common Stock, $.01 par value, From Listing and 
Registration on the American Stock Exchange LLC; File No. 1-10352

February 19, 2004.
    Columbia Laboratories, Inc., a Delaware corporation (``Issuer''), 
has filed an application with the Securities and Exchange Commission 
(``Commission''), pursuant to section 12(d) of the Securities Exchange 
Act of 1934 (``Act'')\1\ and Rule 12d2-2(d) thereunder,\2\ to withdraw 
its Common Stock, $.01 par value (``Security''), from

[[Page 8709]]

listing and registration on the American Stock Exchange LLC (``Amex'' 
or ``Exchange'').
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78l(d).
    \2\ 17 CFR 240.12d2-2(d).
---------------------------------------------------------------------------

    The Board of Directors (``Board'') of the Issuer unanimously 
approved a resolution on September 18, 2003 to withdraw the Issuer's 
Security from listing on the Amex and to list the Security on Nasdaq 
National Market System (``NMS''). The Board states that it deems it 
advisable, and desirable and in the best interest of the Issuer to 
switch the listing of its Security from the Amex to Nasdaq NMS.
    The Issuer stated in its application that it has met the 
requirements of Amex Rule 18 by complying with all applicable laws in 
the State of Delaware, in which it is incorporated, and with the Amex's 
rules governing an issuer's voluntary withdrawal of a security from 
listing and registration.
    The Issuer's application relates solely to the withdrawal of the 
Security from listing on the Amex and shall not affect its continued 
listing on the Nasdaq NMS nor its obligation to be registered under 
section 12(b) of the Act.\3\
---------------------------------------------------------------------------

    \3\ 15 U.S.C. 781(b).
---------------------------------------------------------------------------

    Any interested person may, on or before March 12, 2004, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW., Washington, DC 20549-0609, facts bearing upon 
whether the application has been made in accordance with the rules of 
the Amex and what terms, if any, should be imposed by the Commission 
for the protection of investors. All comment letters should refer to 
File No. 1-10352. The Commission, based on the information submitted to 
it, will issue an order granting the application after the date 
mentioned above, unless the Commission determines to order a hearing on 
the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.\4\
---------------------------------------------------------------------------

    \4\ 17 CFR 200.30-3(a)(1).
---------------------------------------------------------------------------

Jonathan G. Katz,
Secretary.
[FR Doc. 04-4061 Filed 2-24-04; 8:45 am]
BILLING CODE 8010-01-P